Show Notes
We’ve all heard about Ozempic. But there are the GLP-1s we colloquially call “Ozempic” (see also: Wegovy, Mounjaro, Zepbound) and then there’s the cultural role of Ozempic.
Given the price of these drugs, barriers to access, and class implications of weight stigma, this topic presents a unique opening to talk about inequality in health outcomes and the profitable business of individualizing social problems.
In part one of this rare two-part series, we’re covering:
The wage penalties associated with (and relationship between) weight and women, and the parallels between the American attitudes about thinness and wealth
The Danish pharma company that put Europe’s entire economy on its back
A conversation with a 12-year veteran of drug and device advocacy who said some of the surrounding issues represent, and I quote, “everything wrong with health policy in our country,” especially given the shortages, costs, and online pharmacies springing up to bridge that gap with non-FDA-approved solutions
Let’s take a peek at the inside the business of weight loss drugs, and join us here next week for part two.
Transcripts, show notes, production credits, and more can be found at: https://moneywithkatie.com/weight-loss-drugs.
Money with Katie’s mission is to be the intersection where the economic, cultural, and political meet the tactical, practical, personal finance education everyone needs. Learn more about your ad choices. Visit megaphone.fm/adchoices
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.katiegattitassin.com
More from The Money with Katie Show
Well, here we are—for the last time, for now. A couple weeks ago, I wrote an end-of-year letter that functioned like a little “status update” on how I’m feeling moving into 2026. In this episode, I invite back five of my favorite guests for their own check-ins. We talk about:
Today’s guest won’t surprise you if you read the introduction to Rich Girl Nation, which recollected the 2018 event that made me think personal finance might not be solely for people with brown bananas and pocket protectors. Lindsey Stanberry, founding editor of Refinery29’s Money Diaries turned media entrepreneur, joins me for the penultimate episode to talk about:
Rebecca Herbst reached financial independence at age 32 during the tenuous early days of the pandemic, and volunteered shortly thereafter to be furloughed from her job in commercial real estate—and so began her (extremely) early retirement.
How do you solve a problem like the disconnect between “wages employers are willing to pay” and “wages employees need to survive”? If you’re my guest this week, the answer is: a wage subsidy.
Since I spent last week’s episode detailing the thrilling ins and outs of making your own 2026 financial plan for wealth-maxxing, today I’m taking a hard left turn and interviewing Andrew Hartman, a history professor and the author of Karl Marx in America, a 500-page tome about which he says, and here I quote directly, “My father-in-law told me that he likes the book even though he still doesn’t like Marx.” We talked about: